ISRCTN16170657已完成未知
A Multi-center, Prospective, Randomized Crossover Study with the NightBalance Lunoa SPT Compared to Positive Airway Pressure (PAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- Philips
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Subject is adult
- •2. Either:
- •2.1. Treatment naïve, or
- •2.2. PAP non-complier (defined as current AAP user with <3 hours per night in the last 3 months per compliance download), and willing to use the APAP device per protocol
- •3. Diagnosis of POSA meeting all the following criteria per control PSG within 6 months of screening:
- •3.1. AHI of >15 during PSG with symptoms of sleepiness per Investigator discretion, or AHI of >15 during respiratory polygraphy with comorbidities (e.g. atrial fibrillation, resistant hypertension, etc.)
- •3.2. Supine AHI at least twice the lateral AHI
- •3.3. Lateral AHI <10
- •3.4. Supine time >30% and <70%
- •4. Understands the study protocol and is willing and able to comply with study requirements and sign informed consent. APAP non-compliant subjects must be willing to use their APAP device per protocol.
排除标准
- •1. Prior or current therapy or treatment for OSA (for Treatment naïve group); Greater than an average of 3 hours per night of APAP use (in the APAP non-complier group)
- •2. A female of child-bearing potential that is pregnant or intends to become pregnant
- •3. Any unstable or severe medical condition of any organ system that at the discretion of the site Principal Investigator (PI) might affect the patient’s participation in the study or generalization of treatment results
- •4. Taking medication that at the discretion of the site Principal Investigator (PI) might affect the patient’s participation in the study or generalization of treatment results
- •5. Oxygen use
- •6. The presence of any other sleep disorder (central sleep apnea (CSA >5), periodic limb movement disorder (PLMAI >15), clinical diagnosis of insomnia or narcolepsy)
- •7. Excessive alcohol consumption (>21 drinks/week)
- •8. The use of any illegal drug(s), per subject report
- •9. Night or rotating shift work
- •10. Severe claustrophobia
- •11. Shoulder, neck, or back complaints that restrict sleeping position
- •12. Subject requires use of more than 2 pillows under the head while sleeping or sleeps in a bed/chair with raised upper body position
研究者
相似试验
已完成
不适用
A multicenter, prospective, randomised, cross-over, exploratory, open pilot study to evaluate the influence on METAbolomics and PROteomics in end stage renal disease patients with post-dilution On-LINE-HDF versus conventional haemodialysisN28.9Disorder of kidney and ureter, unspecifiedDRKS00010917niversitätsklinik für Innere Medizin, Abteilung für Nephrologie20
进行中(未招募)
不适用
A Study of Two Different Adalimumab Formulations in Adults withRheumatoid Arthritis.EUCTR2011-002275-41-CZAbbott GmbH & Co. KG60
进行中(未招募)
不适用
A Study of Two Different Adalimumab Formulations in Adults with Rheumatoid Arthritis.Rheumatoid Arthritis.MedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2011-003953-25-DEAbbott GmbH & Co. KG60
进行中(未招募)
不适用
A Study of Two Different Adalimumab Formulations in Adults withRheumatoid Arthritis.Rheumatoid Arthritis.MedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2011-002275-41-BEAbbott GmbH & Co. KG60
进行中(未招募)
1 期
oEUCTR2013-002783-12-DEBayer HealthCare AG24
